Helicobacter pylori infects approximately 50% of the world's population and is considered
the major etiological agent of severe gastric diseases, such as peptic ulcers and gastric …

Helicobacter pylori infection exhibits a wide disease spectrum ranging from asymptomatic
gastritis, peptic ulcer disease, to gastric cancer. H. pylori can induce dysbiosis of gastric …

Helicobacter pylori remains a major health problem worldwide, causing considerable
morbidity and mortality due to peptic ulcer disease and gastric cancer. The burden of …

Background: Helicobacter pylori (H. pylori) infection is important risk factors for chronic
gastritis, peptic ulcer and gastric cancer. Bismuth-containing quadruple therapy has recently …

We evaluated the primary resistance of Helicobacter pylori (H. pylori) to routinely used
antibiotics in Cambodia, an unexplored topic in the country, and assessed next-generation …

Evaluation of Helicobacter pylori resistance to antibiotics is crucial for treatment strategy in
Myanmar. Moreover, the genetic mechanisms involved remain unknown. We aimed to …

Helicobacter pylori (H. pylori) eradication by antibiotics and proton pump inhibitor treatment
is limited by the low pH microenvironment in the stomach and can lead to antibiotic …

Helicobacter pylori is a pathogenic bacterium that infects the stomach, causing chronic
gastritis; and it is also considered to be related to the occurrence of gastric cancers …

Abstract Background Multidrug‐resistant Helicobacter pylori strains are emerging in
Southeast Asia. This study evaluates the region's real‐world practice in H. pylori …

Potassium-competitive acid blockers (P-CABs) provide potent acid inhibition, yet studies on
P-CAB-based quadruple therapy for H. pylori eradication are limited. We theorized that …